Melfa Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$850K Buy
6,655
+10
+0.2% +$1.25K 0.49% 49
2025
Q4
$810K Hold
6,645
0.47% 57
2025
Q3
$666K Hold
6,645
0.39% 67
2025
Q2
$551K Hold
6,645
0.35% 71
2025
Q1
$539K Hold
6,645
0.36% 71
2024
Q4
$598K Hold
6,645
0.4% 65
2024
Q3
$657K Hold
6,645
0.43% 58
2024
Q2
$616K Hold
6,645
0.43% 59
2024
Q1
$631K Hold
6,645
0.46% 55
2023
Q4
$593K Buy
6,645
+1
+0% +$74 0.56% 47
2023
Q3
$485K Hold
6,644
0.53% 51
2023
Q2
$553K Hold
6,644
0.56% 49
2023
Q1
$506K Hold
6,644
0.51% 50
2022
Q4
$551K Buy
+6,644
New +$538K 0.58% 48

Other funds holding XBI